PharmApprove- A division of Taft and Partners
Who We Are

PharmApprove is a leader in the field of strategic regulatory and drug development communications. Founded in 1999, the firm has trained more than 500 scientists, physicians, statisticians, and regulatory professionals how to deliver clear, concise and compelling communications to regulators worldwide.

Our core offering is our FDA Advisory Committee Preparation Practice, which helps teams deliver powerful presentations and prepare to answer questions persuasively using time-tested methodologies we’ve created over the course of over 50 projects.

We use the same methods in our Drug Development Communications Practice, where we leverage our extensive knowledge of product development and deep commercial experience to help teams make better decisions that foster product success.

Simply put, PharmApprove helps your team deliver the right communications at the right time. As one regulatory vice-president put it, “PharmApprove brings significant added value to our business, and is a critical business partner for us in managing complex communications issues...”

photo
about us
Our Team
News
what we do
our services
our success
Clients
Therapeutic Areas
Case Studies
 
contact us
Podcast Icon
FDA Advisory Committee Process
Pete Taft interviews Douglas Greene, Senior Vice President and Senior Scientific Advisor for Sanofi-Aventis about the changing landscape of FDA Advisory Committee hearings.
Listen Now
© 2010 PharmApprove. All Rights Reserved.   Privacy Policy | Terms & Conditions | Site Map
PharmApproveVisit Taft and Partners